Bio Tech/Life SciencesHealthtechHealth and wellnessB2CB2B1-5 employees
First-Time Founder
Female FounderActively RaisingAbout
We turn mucus into medicine—first-in-class mucin-mimetic barrier therapies for mucosal defense. Tulip’s modular glycopolymer platform develops synthetic mucin analogs that reproduce the protective functions of natural mucus to restore barrier function and prevent recurrent infections.
Products
TLP-401 Barrier Repair Gel
Synthetic mucin-mimetic vaginal gel for bacterial vaginosis prevention and mucosal defense. Restores vaginal barrier function by attenuating pathogens, supporting beneficial microbiota like L. crispatus, and protecting tissue integrity. Demonstrated 74% decrease in antibiotic-tolerant biofilms, 6x increase in beneficial bacteria growth, and 82% decrease in vaginal cell death and inflammation.
Click to read more